Evaluation of applicability of SLFIA method to monitoring carbamazepine concentration in plasma. Comparison with EMIT and HPLC methods.

@inproceedings{Akita1985EvaluationOA,
  title={Evaluation of applicability of SLFIA method to monitoring carbamazepine concentration in plasma. Comparison with EMIT and HPLC methods.},
  author={Masahiro Akita and Masahiko Shinoda and Yoshiro Yokochi and Sueharu Nakano and Shikifumi Kitazawa and Masayoshi Terashima},
  year={1985}
}
Concentrations of carbamazepine (CBZ) in plasma were measured by AMES TDATM carbamazepine kit, a newly developed substrate-labeled fluorescent immunoassay (SLFIA). The study produced results which showed good correlation with those of homogeneous enzyme immunoassay (EMIT) and high-performance liquid chromatography (HPLC). There was a significant correlation in the plasma concentrations between SLFIA and EMIT methods (n= 92, r= 0.994, p<0.01), whereas a high correlation between SLFIA and HPLC… CONTINUE READING